Author reply [0.03%]
作者回复
Helen Luo,Paul Finlay,Garun S Hamilton et al.
Helen Luo et al.
Patient-reported outcomes in Australian oncology: from emerging practice to system-wide care [0.03%]
澳大利亚肿瘤学中的患者报告结果指标：从新兴实践到系统化护理
Marianne Holly Clausen,Carolyn Mazariego,Julia Lai-Kwon et al.
Marianne Holly Clausen et al.
From exclusion to engagement and enrolment: single institutional experience of recruiting Aboriginal and Torres Strait Islander peoples for a genomic sequencing study [0.03%]
从排斥到参与和注册：单机构招募土著居民和托雷斯海峡岛民进行基因组测序研究的经验
Michail Charakidis,Halli Waran,Yat Ming Lau et al.
Michail Charakidis et al.
Indigenous peoples remain under-represented in genomic research and clinical trials. This reflects historical exclusion, mistrust and health system barriers. In this article, we describe a single Australian institution's experience in impro...
Tigecycline combination therapy for fulminant Clostridioides difficile infection: an Australian experience [0.03%]
特格 cycline 联合治疗难辨梭菌引起的爆发性感染：澳大利亚的治疗经验
Emma Bishop,Tanya Ravipati,Steven Mileto et al.
Emma Bishop et al.
Background: Recent European Society of Clinical Microbiology and Infection and Australasian Society of Infectious Diseases Clostridioides difficile infection (CDI) management guidelines endorse the addition of intravenous...
Cost-consequence analysis of models of general medicine perioperative care in Victorian hospitals [0.03%]
维多利亚州医院一般医学围手术期护理模式的成本后果分析
Geoffrey Lester,Amy Osborne,Rona Zhao et al.
Geoffrey Lester et al.
Australian general medicine perioperative services provide care to surgical patients with complex comorbidities, for a wide range of medical conditions. Heterogeneous models of care exist; however, their cost-consequence has not been evalua...
Dose escalation for secondary loss of response in inflammatory bowel disease: 3-year outcomes and treatment persistence [0.03%]
炎症性肠病二次失应答的剂量递增：3年预后和治疗持续性
Faris Gondal,Maddison Terlato,Omar Salehi et al.
Faris Gondal et al.
Background: Dose escalation of biologic therapies is commonly used to manage secondary loss of response in inflammatory bowel disease, although long-term real-world outcomes remain limited. ...
Anticoagulation stewardship team oversight of enoxaparin-warfarin bridging delivered by Hospital in the Home: a pre- and post-implementation study [0.03%]
门诊医院达比加群桥接治疗的抗凝 stewardship 团队监管:一项实施前和实施后的研究
Suebsakul Pripanapong,Sing Ning Yeoh,Jahan Zaib et al.
Suebsakul Pripanapong et al.
Background: Initiation or re-initiation of warfarin often requires enoxaparin bridging, a period associated with increased bleeding risk. Anticoagulation stewardship (ACS) teams may improve the safety of anticoagulant man...
Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors [0.03%]
澳大利亚针对补体抑制剂治疗神经疾病成人患者中脑膜炎球菌感染风险增加的管理共识建议
Katherine A Buzzard,Michael Barnett,Heidi Beadnall et al.
Katherine A Buzzard et al.
Complement inhibitor therapy carries a risk of serious infections, including meningococcal disease. Here we provide evidence-based recommendations and expert consensus for immunisation and prophylactic treatment of patients receiving, or pl...
Adjunctive metformin therapy in type 1 diabetes in pregnancy: insights from an Australian cohort [0.03%]
妊娠1型糖尿病患者使用二甲双胍辅助治疗的临床疗效：来自澳大利亚队列的启示
Mauli Govinna,Joanna Gong,Jessica Triay et al.
Mauli Govinna et al.
Metformin has gained attention as a potential adjunct therapy in pregnant women with type 1 diabetes mellitus (T1DM), although evidence is limited. We present the first reported experience of metformin use in pregnant women living with T1DM...
The effect of socioeconomic background on fatigue burden in Inflammatory Bowel Disease [0.03%]
社会经济背景对炎症性肠病患者疲劳负担的影响
Nishani Kulendiran
Nishani Kulendiran